novalix-Justine Wanner GPCRs

Membrane proteins are privileged therapeutic targets representing about 40% currently marketed drugs, but GPCRs remain particularly challenging and competitive. The continuous development of in-house knowledge and expertise is essential. 

For Justine, studying at the School of Engineering in Biotechnology (ESBS, Illkirch) and in parallel a master’s degree in pharmaceutical biotechnology (Faculty of Pharmacy, Illkirch)—with a specialization in bioproduction, this subject is a very formative experience for her. Justine’s internship focuses on new approaches for preparing GPCRs that are suitable for structural determination using cryo-electron microscopy. This experience will improve her knowledge and skills in sample preparation, structural biology, and biophysical techniques—such as protein X-ray crystallography and mass spectrometry.  

“I am learning to design specific protocols based on publications and adapting them according to my results; also, I am increasing my knowledge of different purification strategies, performing them almost autonomously, which is particularly enriching for me.”  

Commented, Justine. 

We warmly welcome and support Justine’s start as a researcher in the pharmaceutical industry. Certainly, it will be a fruitful experience for all.

If you want to know more about what it’s like to work with us visit “Life at NovAliX

Special thanks to Justine Wanner and Gilbert Bey for their contributions to this post.

This website uses cookies to improve user experience